ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesF12.180

F12.180

Billable

Cannabis abuse with cannabis-induced anxiety disorder

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 F12.180 is a billable code used to indicate a diagnosis of cannabis abuse with cannabis-induced anxiety disorder.

Key Diagnostic Point:

Cannabis abuse with cannabis-induced anxiety disorder refers to a pattern of cannabis use that leads to clinically significant impairment or distress, characterized by the development of anxiety symptoms directly attributable to cannabis use. This condition is marked by the recurrent use of cannabis despite experiencing negative consequences, such as anxiety, panic attacks, or exacerbation of pre-existing anxiety disorders. Patients may present with symptoms such as excessive worry, restlessness, irritability, and physical symptoms like increased heart rate or sweating when using cannabis. The diagnosis requires a thorough assessment to differentiate between primary anxiety disorders and those induced by cannabis. Treatment typically involves a combination of behavioral therapies, psychoeducation, and support groups, with a focus on abstinence from cannabis and management of anxiety symptoms through cognitive-behavioral strategies or pharmacotherapy when necessary.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Differentiating between primary anxiety disorders and cannabis-induced anxiety.
  • Understanding the nuances of cannabis use patterns and their impact on mental health.
  • Navigating the legal and regulatory aspects of cannabis use in different states.
  • Documenting the severity and duration of symptoms accurately.

Audit Risk Factors

  • Inadequate documentation of the relationship between cannabis use and anxiety symptoms.
  • Failure to document the severity and frequency of cannabis use.
  • Lack of comprehensive treatment plans addressing both cannabis use and anxiety.
  • Inconsistent coding of co-occurring mental health disorders.

Specialty Focus

Medical Specialties

Psychiatry

Documentation Requirements

Detailed patient history, including substance use history and mental health evaluations.

Common Clinical Scenarios

Patients presenting with anxiety symptoms after cannabis use, or those with a history of anxiety disorders exacerbated by cannabis.

Billing Considerations

Consideration of comorbid mental health conditions and the need for a multidisciplinary approach.

Addiction Medicine

Documentation Requirements

Comprehensive assessment of substance use patterns and their impact on mental health.

Common Clinical Scenarios

Patients seeking treatment for cannabis use disorder with associated anxiety symptoms.

Billing Considerations

Focus on harm reduction strategies and the importance of patient education regarding cannabis effects.

Coding Guidelines

Inclusion Criteria

Use F12.180 When
  • According to ICD
  • 10 guidelines, F12
  • 180 should be used when there is clear evidence of cannabis abuse leading to anxiety symptoms
  • Documentation must support the diagnosis, including the timeline of cannabis use and the onset of anxiety symptoms

Exclusion Criteria

Do NOT use F12.180 When
  • Exclusion criteria include primary anxiety disorders not related to cannabis use

Related ICD-10 Codes

Related CPT Codes

96127CPT Code

Brief emotional/behavioral assessment

Clinical Scenario

Used when assessing anxiety symptoms in patients with cannabis use.

Documentation Requirements

Document the assessment findings and treatment recommendations.

Specialty Considerations

Psychiatric evaluations should include substance use history.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of cannabis-related disorders, improving the ability to track and treat cannabis abuse and its mental health implications more effectively.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of cannabis-related disorders, improving the ability to track and treat cannabis abuse and its mental health implications more effectively.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of cannabis-related disorders, improving the ability to track and treat cannabis abuse and its mental health implications more effectively.

Resources

Clinical References

  • •
    Substance Abuse and Mental Health Services Administration (SAMHSA)

Coding & Billing References

  • •
    Substance Abuse and Mental Health Services Administration (SAMHSA)

Frequently Asked Questions

What is the difference between cannabis abuse and cannabis dependence?

Cannabis abuse refers to the harmful use of cannabis that leads to significant impairment or distress, while cannabis dependence involves a stronger compulsion to use cannabis, often characterized by withdrawal symptoms and tolerance.